Mitchell Finer

Mitchell Finer

Direttore/Membro del Consiglio presso PEPGEN INC.

Patrimonio netto: - $ in data 31/05/2026

67 anni
Health Technology
Consumer Services
Finance

Profilo

Mitchell H.
Finer
founded Cell Genesys, Inc. in 1989, where he worked as Vice President-Research from 1989 to 1999, Adverum Biotechnologies, Inc. in 2006, where he worked as Director from 2006 to 2019, Oncorus, Inc. in 2015, where he worked as Director in 2023, ElevateBio LLC in 2017, where he worked as Director, President-Research & Development from 2017 to 2024, and CODA Biotherapeutics, Inc. in 2014, where he worked as Director from 2014 to 2022.
Dr. Finer also founded Abgenix, Inc., where he worked as Principal.
Dr. Finer also currently works at Abata Therapeutics, Inc., as Director, Tabby Therapeutics Ltd., as Director, and PepGen Inc., as Independent Non-Executive Director from 2025.
Dr. Finer also formerly worked at Intracel Corp., as Chief Executive Officer from 2005 to 2007, Genteric, Inc., as President & Chief Executive Officer from 2003 to 2005, Intracel Resources LLC, as Chief Executive Officer, Intracel Holdings Corp., as Chief Executive Officer from 2005 to 2008, LifeEDIT Therapeutics, Inc., as Chief Executive Officer, MPM BioImpact LLC, as Managing Director, Candel Therapeutics, Inc., as Director, TCR² Therapeutics, Inc., as Independent Director from 2015 to 2020, Semma Therapeutics, Inc., as Director, Turmeric Acquisition Corp., as Independent Director, SaviCorp, as Vice President-Research & Development, ViaCyte, Inc., as Senior Vice President-Development from 2008 to 2010, Aventis Pharmaceuticals, Inc., as Vice President-Gencell Division from 1999 to 2002, Sanofi India Ltd., as Vice President-Research, Genetix Biotherapeutics, Inc., as Chief Scientific Officer from 2010 to 2015, and Elevatebio Base Camp, Inc., as President from 2019 to 2021.
Dr. Finer received his doctorate degree in 1986 from Harvard University and undergraduate degree in 1979 from the University of California, Berkeley.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
18/06/2026 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Mitchell Finer

SocietàPosizioneInizio
PEPGEN INC. Direttore/Membro del Consiglio 27/03/2025
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Mitchell Finer

SocietàPosizioneFine
Fondatore 01/05/2024
ONCORUS, INC. Amministratore Delegato 01/07/2018
Fondatore 01/10/2022
Presidente 01/12/2021
TCR2 THERAPEUTICS INC. Direttore/Membro del Consiglio 04/05/2020
Vedi nel dettaglio l'esperienza di Mitchell Finer

Formazione di Mitchell Finer

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

71

Relazioni di 1° grado

27

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private27

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Mitchell Finer